Analystreport

Keryx Biopharmaceuticals (NASDAQ: KERX) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.

KERYX BIOPHARMACEUTICALS  (KERX) 
Last keryx biopharmaceuticals earnings: 11/8 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.keryx.com/investor-overview